Epithelial-Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma.
colorectal adenocarcinoma
epithelial–mesenchymal transition
prognostic markers
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
26 May 2021
26 May 2021
Historique:
received:
06
04
2021
revised:
13
05
2021
accepted:
21
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Colon adenocarcinoma (COAD) remains an important cause of cancer-related mortality worldwide. Epithelial-mesenchymal transition (EMT) is a key mechanism, promoting not only the invasive or metastatic phenotype but also resistance to therapy. Using bioinformatics approaches, we studied the alteration on EMT related genes and its implication on COAD prognostic based on public datasets. For the EMT mechanisms, two overexpressed genes were identified (NOX4 and IGF2BP3), as well as five downregulated genes (BMP5, DACT3, EEF1A2, GCNT2 and SFRP1) that were related to prognosis in COAD. A qRT-PCR validation step was conducted in a COAD patient cohort comprising of 29 tumor tissues and 29 normal adjacent tissues, endorsing the expression level for BMP5, as well as for two of the miRNAs targeting key EMT related genes, revealing upregulation of miR-27a-5p and miR-146a-5p. The EMT signature can be used to develop a panel of biomarkers for recurrence prediction in COAD patients, which may contribute to the improvement of risk stratification for the patients.
Identifiants
pubmed: 34073426
pii: jpm11060476
doi: 10.3390/jpm11060476
pmc: PMC8229043
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Biosci Rep. 2019 Dec 20;39(12):
pubmed: 31763673
Am J Cancer Res. 2020 Aug 01;10(8):2480-2494
pubmed: 32905413
Semin Cancer Biol. 2012 Oct;22(5-6):404-10
pubmed: 22706095
Cancers (Basel). 2017 Dec 16;9(12):
pubmed: 29258163
Br J Cancer. 2021 Jan;124(1):259-269
pubmed: 33299129
Dig Dis Sci. 2018 Sep;63(9):2332-2340
pubmed: 29781053
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28600395
Sci Rep. 2016 Aug 23;6:31852
pubmed: 27549611
Int J Mol Sci. 2019 Dec 05;20(24):
pubmed: 31817513
Biomed Pharmacother. 2020 Jun;126:110099
pubmed: 32179200
J Cell Physiol. 2019 Aug;234(10):18466-18479
pubmed: 30895618
Onco Targets Ther. 2018 May 15;11:2815-2830
pubmed: 29844680
Theranostics. 2020 Jan 12;10(5):1981-1996
pubmed: 32104496
J Exp Clin Cancer Res. 2018 Oct 20;37(1):257
pubmed: 30342533
Methods Mol Biol. 2018;1819:215-233
pubmed: 30421406
Biomolecules. 2019 Sep 26;9(10):
pubmed: 31561501
J Gastrointestin Liver Dis. 2015 Jun;24(2):225-34
pubmed: 26114183
J Exp Clin Cancer Res. 2019 Oct 29;38(1):433
pubmed: 31665050
Oncogene. 2020 Jul;39(28):5152-5164
pubmed: 32535615
Oncotarget. 2017 May 16;8(20):33586-33600
pubmed: 28422720
J BUON. 2014 Apr-Jun;19(2):502-11
pubmed: 24965413
Cancer Immunol Res. 2016 Nov;4(11):927-935
pubmed: 27737877
Exp Ther Med. 2018 Aug;16(2):1241-1249
pubmed: 30116375
BMC Med Genomics. 2018 Aug 08;11(1):63
pubmed: 30089500
Anticancer Res. 2015 Mar;35(3):1411-21
pubmed: 25750292
Eur J Cancer. 2012 Dec;48(18):3405-13
pubmed: 22840368
Front Genet. 2020 Mar 20;11:192
pubmed: 32265979
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
BMC Cancer. 2020 Nov 23;20(1):1135
pubmed: 33228590
Biomed Res Int. 2019 Sep 29;2019:2962580
pubmed: 31781608
Tumour Biol. 2014 Jun;35(6):5101-10
pubmed: 24504677
BMJ. 2016 Jul 14;354:i3590
pubmed: 27418368
Sci Rep. 2020 Feb 27;10(1):3652
pubmed: 32107458
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Oncoscience. 2015 Jul 01;2(6):607-14
pubmed: 26244168
Nucleic Acids Res. 2020 Jul 2;48(W1):W244-W251
pubmed: 32484539
Mol Cancer. 2018 Dec 20;17(1):176
pubmed: 30572883
Mol Aspects Med. 2019 Dec;70:90-105
pubmed: 31703947
J Proteome Res. 2014 Nov 7;13(11):4910-8
pubmed: 25096929
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Free Radic Biol Med. 2012 Oct 1;53(7):1489-99
pubmed: 22728268
Cancers (Basel). 2019 Oct 22;11(10):
pubmed: 31652660
Cancers (Basel). 2021 Jan 20;13(3):
pubmed: 33498377
Cancer Res. 2020 May 1;80(9):1846-1860
pubmed: 32122909
Cancers (Basel). 2020 Oct 20;12(10):
pubmed: 33092068
PLoS One. 2011;6(10):e24429
pubmed: 22022355
Tumour Biol. 2017 May;39(5):1010428317698365
pubmed: 28466779
Cancer Cell. 2008 Jun;13(6):529-41
pubmed: 18538736
J Dig Dis. 2018 Oct;19(10):578-585
pubmed: 30058122
Int J Mol Sci. 2019 Mar 09;20(5):
pubmed: 30857282
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Cell Death Dis. 2018 Jan 19;9(2):66
pubmed: 29352232
Mol Cell Biochem. 2013 Sep;381(1-2):61-8
pubmed: 23881244
Cancers (Basel). 2019 Apr 30;11(5):
pubmed: 31052265
Cancers (Basel). 2020 Mar 31;12(4):
pubmed: 32244548
Cancers (Basel). 2019 May 24;11(5):
pubmed: 31137625
Cancer Res. 2018 Nov 1;78(21):6320-6328
pubmed: 30232219
Int J Mol Sci. 2017 Jul 13;18(7):
pubmed: 28703782
Cancer Res. 2015 May 1;75(9):1789-800
pubmed: 25744723